| Browse All

Zhengye Biotechnology Holding Limited (ZYBT)

Healthcare | Drug Manufacturers - Specialty & Generic | Jilin, China | NasdaqCM
0.99 USD -0.04 (-3.835%) ⇩ (April 17, 2026, 4 p.m. EDT)
After hours: 0.99

Short-term: ★★★★☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 19, 2026, 12:41 a.m. EDT

Hot take: Despite deteriorating fundamentals (revenue -34%, negative margins) and a significant gap from the 50-day average, the stock is trading near recent highs showing strong short-term momentum, but the high entropy forecast (H-stat 17.48) and negative directional prediction warn of potential exhaustion ahead.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.178979
AutoETS0.207614
AutoTheta0.224093
MSTL0.229342

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 42%
H-stat 17.48
Ljung-Box p 0.000
Jarque-Bera p 0.152
Excess Kurtosis -0.75
Attribute Value
Sector Healthcare
Debt to Equity Ratio 23.491
Revenue per Share 3.307
Market Cap 46,941,156
Profit Margins -12.60%
Website https://www.jlzybio.com

Info Dump

Attribute Value
52 Week Change -0.8712987
Address1 No.1 Lianmeng Road
Address2 Jilin Eco & Technical Dev Zn
All Time High 14.3
All Time Low 0.68
Ask 1.24
Ask Size 2
Average Daily Volume10 Day 28,520
Average Daily Volume3 Month 215,529
Average Volume 215,529
Average Volume10Days 28,520
Bid 0.7184
Bid Size 2
Book Value 0.91483665
City Jilin
Country China
Crypto Tradeable 0
Currency USD
Current Price 0.9905
Current Ratio 1.494
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 1.0518
Day Low 0.96
Debt To Equity 23.491
Display Name Zhengye Biotechnology Holding
Ebitda -2,213,000
Ebitda Margins -0.01439
Enterprise To Ebitda -68.344
Enterprise To Revenue 0.984
Enterprise Value 151,245,152
Eps Trailing Twelve Months -0.06
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 0.89518
Fifty Day Average Change 0.09531999
Fifty Day Average Change Percent 0.106481366
Fifty Two Week Change Percent -87.12987
Fifty Two Week High 14.3
Fifty Two Week High Change -13.3095
Fifty Two Week High Change Percent -0.9307342
Fifty Two Week Low 0.68
Fifty Two Week Low Change 0.31049997
Fifty Two Week Low Change Percent 0.4566176
Fifty Two Week Range 0.68 - 14.3
Financial Currency CNY
First Trade Date Milliseconds 1,736,260,200,000
Float Shares 4,418,772
Free Cashflow 24,229,624
Full Exchange Name NasdaqCM
Full Time Employees 277
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.37373
Gross Profits 57,455,000
Has Pre Post Market Data 1
Held Percent Insiders 5.84755
Held Percent Institutions 0.03121
Implied Shares Outstanding 47,391,377
Industry Drug Manufacturers - Specialty & Generic
Industry Disp Drug Manufacturers - Specialty & Generic
Industry Key drug-manufacturers-specialty-generic
Ipo Expected Date 2,025-01-07
Language en-US
Last Fiscal Year End 1,735,603,200
Long Business Summary Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Long Name Zhengye Biotechnology Holding Limited
Market us_market
Market Cap 46,941,156
Market State PREPRE
Max Age 86,400
Message Board Id finmb_1858707878
Most Recent Quarter 1,751,241,600
Net Income To Common -19,368,000
Next Fiscal Year End 1,767,139,200
Non Diluted Market Cap 45,969,634
Open 0.96
Operating Cashflow 12,389,000
Operating Margins -0.46333998
Payout Ratio 0.0
Phone 86 432 6304 7008
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 0.9905
Post Market Time 1,776,456,605
Previous Close 1.03
Price Hint 4
Price To Book 1.0827069
Price To Sales Trailing12 Months 0.3053381
Profit Margins -0.12597999
Quick Ratio 1.005
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.0395
Regular Market Change Percent -3.83495
Regular Market Day High 1.0518
Regular Market Day Low 0.96
Regular Market Day Range 0.96 - 1.0518
Regular Market Open 0.96
Regular Market Previous Close 1.03
Regular Market Price 0.9905
Regular Market Time 1,776,456,000
Regular Market Volume 8,959
Return On Assets -0.03446
Return On Equity -0.0638
Revenue Growth -0.344
Revenue Per Share 3.307
Sand P52 Week Change 0.38150132
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 47,391,376
Shares Percent Shares Out 0.0031
Shares Short 147,787
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 20,412
Short Name Zhengye Biotechnology Holding L
Short Percent Of Float 0.0334
Short Ratio 0.26
Source Interval 15
Symbol ZYBT
Total Cash 47,628,000
Total Cash Per Share 1.005
Total Debt 85,763,000
Total Revenue 153,735,008
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.06
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 3.241845
Two Hundred Day Average Change -2.251345
Two Hundred Day Average Change Percent -0.6944641
Type Disp Equity
Volume 8,959
Website https://www.jlzybio.com
Zip 132,101